Replimune (REPL) Non Operating Income (2017 - 2025)

Replimune's (REPL) quarterly Non Operating Income came in at -$580000.0 in Q4 2025, down 328.35% year-on-year from $254000.0 in Q4 2024, and up 33.79% quarter-over-quarter from -$876000.0 in Q3 2025.

Replimune (REPL) Non Operating Income (2017 - 2025) Analysis & Trends

Replimune has disclosed Non Operating Income across 9 years of filings, most recently posting -$580000.0 for Q4 2025.

  • Non Operating Income for Q4 2025 came in at -$580000.0, down 328.35% year-over-year; the trailing twelve-month figure through Dec 2025 was -$217000.0 (down 100.88% YoY), and the FY2025 annual result was -$202000.0, down 101.04% from the prior year.
  • Non Operating Income came in at -$580000.0 for Q4 2025 at Replimune, up from -$876000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $18.1 million in Q1 2024 to a low of -$8.6 million in Q4 2023.
  • The 5-year median for Non Operating Income is $115500.0 (2021), against an average of $990350.0.
  • Across the five-year window, Non Operating Income slumped 5931.97% in 2023 and surged 1679.04% in 2024, its largest moves.
  • Replimune's Non Operating Income stood at $24000.0 in 2021, then surged by 512.5% to $147000.0 in 2022, then plunged by 5931.97% to -$8.6 million in 2023, then surged by 102.96% to $254000.0 in 2024, then plunged by 328.35% to -$580000.0 in 2025.
  • The last three Non Operating Income figures came in at -$580000.0 (Q4 2025), -$876000.0 (Q3 2025), and $591000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 5.75 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 444,000.00
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - 9.35 Mn
10 Replimune 780.01 Mn 510.88 Mn - -580,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -580,000.00
Sep 30, 2025 -876,000.00
Jun 30, 2025 591,000.00
Mar 31, 2025 648,000.00
Dec 31, 2024 254,000.00
Sep 30, 2024 5.86 Mn
Jun 30, 2024 406,000.00
Mar 31, 2024 18.08 Mn
Dec 31, 2023 -8.57 Mn
Sep 30, 2023 3.59 Mn
Jun 30, 2023 6.29 Mn
Mar 31, 2023 -1.15 Mn
Dec 31, 2022 147,000.00
Sep 30, 2022 -2.66 Mn
Jun 30, 2022 -2.02 Mn
Mar 31, 2022 292,000.00
Dec 31, 2021 24,000.00
Sep 30, 2021 -356,000.00
Jun 30, 2021 -252,000.00
Mar 31, 2021 84,000.00